Genoptix, Inc. (NASDAQ: GXDX) and HistoRx, Inc. today announced a multi-year licensing agreement for AQUA technology and several diagnostic assays ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE